Ronan Swords
Associate Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine · Oregon Health & Science University
Credentials: · · · · ·
History

- 2000–2003
Internal Medicine
Research
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
New England Journal of Medicine · 2018 · 1,234 citations
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Blood · 2017 · 1,232 citations
Functional genomic landscape of acute myeloid leukaemia
Nature · 2018 · 1,111 citations
- FG
49 papers

17 papers
- ET
17 papers

17 papers

16 papers

15 papers

13 papers

13 papers
Grants
- 2016–2018
Unlocking the Therapeutic Potential of Retinoic Acid in Acute Myeloid Leukemia
National Cancer Institute · R21
Contact PI · $200.3K · University of Miami School of Medicine
Clinical trials
- 2022–2026
Principal investigator · Active not recruiting · Phase 1
OHSU Knight Cancer Institute
- 2022–2027
Site PI · Recruiting · Phase 1, Phase 2
Disc Medicine, Inc
- 2016–2032
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
Site PI · Recruiting · Phase 2, Phase 3
Beat AML, LLC


